Prognostic factors for poor outcomes in patients with severe COVID-19 treated with remdesivir plus dexamethasone in Taiwan
Background: Coronavirus disease-2019 (COVID-19) remains a global public health concern, and remdesivir plus dexamethasone combination therapy is suggested for patients with severe disease. However, the factors associated with poor outcomes in these patients remain unclear. We identified the factors...
| Main Authors: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | English |
| Publicado: |
Elsevier
2023-12-01
|
| Series: | Journal of Microbiology, Immunology and Infection |
| Subjects: | |
| Acceso en liña: | http://www.sciencedirect.com/science/article/pii/S1684118223001585 |